Filings buzz in pharmaceuticals: 24% increase in artificial intelligence mentions in Q2 2021

Robert Marcus
Nov 8, 2021

Related news

Feb 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Can tech for good be as profitable as plain old tech?

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence In Drug Discovery

Jan 11
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pfizer and PostEra collab in $250M AI lab deal

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Oct 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Big-name U.S. tech investors are moving in on Europe in increasing numbers

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Bridging the ESG Valley of Death

Sep 28
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Vietnam Accelerates Investment in Artificial Intelligence

Nov 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of Artificial Intelligence Compute

Dec 29
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

IPO shows significant growth in healthcare industry

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie